Generic drugs and cornered markets
Written by: Christopher Ward | Published:
Turing Pharmaceuticals not the first generic manufacturer to exorbitantly raise prices
- Category:
Can Indian generics move from blockbusters to biologics?
Written by: Christopher Ward | Published:
Category:For generic dug manufacturers in India and elsewhere the number of blockbuster drugs that have recently come off patent has been a bonanza. But the product mix coming off patent over the next...
Is Indian Pharma’s spectacular growth Bonanza or Bubble?
Written by: Christopher Ward | Published:
Category:Indian pharmaceutical companies’ profits have grown hugely in recent years. Contrary to claims that India’s robust generics industry is driven by being ‘the drug store for the developing world’,...
Generic Drugs In Canada: A Policy Paper
Written by: Christopher Ward | Published:
Category:This Report provides an overview of background information related to the pharmaceutical market both globally and within Canada, followed by a summary of the regulatory mechanisms related to...